logo ECCN european conference of clinical neuroimaging 2025 Madrid Spain

MADRID, Spain 24-26 MARCH, 2025

ABOUT THE EVENT

2025 Annual Meeting: ECCN MADRID

ECCN 2025 Madrid Spain

The 13th European Conference on Clinical Neuroimaging (ECCN, March 24th-26th, 2025) will again bring together physicians and researchers from all brain imaging modalities (from PET to SPECT and MRI) and will also provide a window into other innovative biomarkers, new technologies and emerging areas of clinical neuroimaging.
We look forward to seeing you in Madrid to discuss clinical neuroimaging and science.

 

Javier Arbizu,

Professor and Director of the Department of Nuclear Medicine, University of Navarra and Clinica Universidad de Navarra, Pamplona and MADRID, Spain.

Franck Semah,

Professor, Head of Imaging Department, University Hospital of LILLE, France

SCIENTIFIC COMMITTEE

PRELIMINARY PROGRAM

REGISTRATION & WELCOME COFFEE

150min

WELCOME

15min

LECTURE SESSION 1

Redefining disease categories in dementia

  • Histopathology and Clinical criteria of Limbic-predominant amnestic neurodegenerative syndrome (Pascual Sánchez-Juan, Madrid, Spain)
  • Grey matter volume loss associated with TDP-43 (Alexandre Bejanin, Barcelona, Spain).
  • FDG-PET signature of Limbic-predominant age-related TDP-43 encephalopathy (Michael Grothe, Madrid, Spain)

90min

SATELLITE SYMPOSIUM 1

GE HealthCare

45min

COFFEE BREAK

30min

ORAL COMMUNICATION 1

75min

SATELLITE SYMPOSIUM 2

Spectrum

45min

REGISTRATION

60min

LECTURE SESSION 2

Biomarkers for the assessment of the biological pillars in movement disorders.

  • FDG-PET in the differential diagnosis of parkinsonism (Gloria Martí-Andrés, Pamplona, Spain)
  • Tau PET in 4R tauopathies (TBC)
  • Biological definition of alpha-synuclein disease (Swen Hesse, Leipzig, Germany)
  • Current stage of alpha-synuclein PET tracers (Andrea Varrone, Stockholm, Sweden)

120min

COFFEE BREAK

30min

ORAL COMMUNICATION 2

60min

SATELLITE SYMPOSIUM 3

Life Molecular Imaging

What does AMYPAD study reveal about centiloid relevance for the future clinical setting?
  • 5’ Introduction – Dr. Andrew Stephens
  • 15’ Clinical value of AMYPAD study - Prof. Pierre Payoux
  • 15’ Centiloid recommendations for clinical context-of-use in challenging cases - Dr. Lyduine Collij
  • 10’ Questions & discussion

45min

LUNCH

60min

ORAL COMMUNICATION 3

120min

COFFEE BREAK

30min

AWARDS

15min

SATELLITE SYMPOSIUM 4

GE HealthCare

45min

AFTERWORK

Afterwork for all participants

120min

REGISTRATION

60min

LECTURE SESSION 3

What is new for brain tumors?

  • Advantages and challenges of PET in patients with brain tumors (Norbert Galldiks, Cologne, Germany)
  • Response Assessment in Neuro-Oncology: PET criteria (Nelleke Tolboom, Utrecht, The Netherlands)
  • Radiotherapy planning using Amino Acid PET tracers (Igor Yakushev, Munich, Germany).
  • Update on meningiomas (TBC)

120min

COFFEE

30min

ORAL COMMUNICATION 4

90min

LUNCH

60min

RAPID FIRE SESSION

120 mn

CONCLUSION

CALL FOR ABSTRACTS

ABSTRACTS

Abstracts can be submitted from October 1 to December 16, 2024

REGISTRATION FEES

Physician / Scientist

Early-Bird rates: 390€

(Before Feb 19, 2025)

 

Regular price: 500€

(Feb 19 – March 20, 2025)

 

On site: 550€

(24-26 March)

Industry participant

Early-Bird rates: 590€

(Before Feb 19, 2025)

 

Regular price: 690€

(Feb 19 – March 20, 2025)

 

On site: 740€

(24-26 March)

Student / Resident

Early-Bird rates: 190€

(Before Feb 19, 2025)

 

Regular price: 250€

(Feb 19 – March 20, 2025)

 

On site: 300€

(24-26 March)

SPONSORS 2024

Thanks to our 2024 sponsors for their support

KEY DATES

Copyright 2023 ECCN All rights reserved | LEGAL | Policy Privacy